Literature DB >> 24952892

A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.

Pasquale Anthony Della Rosa1, Chiara Cerami, Francesca Gallivanone, Annapaola Prestia, Anna Caroli, Isabella Castiglioni, Maria Carla Gilardi, Giovanni Frisoni, Karl Friston, John Ashburner, Daniela Perani.   

Abstract

[18F]-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) is a widely used diagnostic tool that can detect and quantify pathophysiology, as assessed through changes in cerebral glucose metabolism. [18F]-FDG PET scans can be analyzed using voxel-based statistical methods such as Statistical Parametric Mapping (SPM) that provide statistical maps of brain abnormalities in single patients. In order to perform SPM, a "spatial normalization" of an individual's PET scan is required to match a reference PET template. The PET template currently used for SPM normalization is based on [15O]-H2O images and does not resemble either the specific metabolic features of [18F]-FDG brain scans or the specific morphological characteristics of individual brains affected by neurodegeneration. Thus, our aim was to create a new [18F]-FDG PET aging and dementia-specific template for spatial normalization, based on images derived from both age-matched controls and patients. We hypothesized that this template would increase spatial normalization accuracy and thereby preserve crucial information for research and diagnostic purposes. We investigated the statistical sensitivity and registration accuracy of normalization procedures based on the standard and new template-at the single-subject and group level-independently for subjects with Mild Cognitive Impairment (MCI), probable Alzheimer's Disease (AD), Frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB). We found a significant statistical effect of the population-specific FDG template-based normalisation in key anatomical regions for each dementia subtype, suggesting that spatial normalization with the new template provides more accurate estimates of metabolic abnormalities for single-subject and group analysis, and therefore, a more effective diagnostic measure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24952892     DOI: 10.1007/s12021-014-9235-4

Source DB:  PubMed          Journal:  Neuroinformatics        ISSN: 1539-2791


  49 in total

1.  Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

Authors:  G Chételat; B Desgranges; V de la Sayette; F Viader; F Eustache; J-C Baron
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

2.  Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

Authors:  K Herholz; E Salmon; D Perani; J C Baron; V Holthoff; L Frölich; P Schönknecht; K Ito; R Mielke; E Kalbe; G Zündorf; X Delbeuck; O Pelati; D Anchisi; F Fazio; N Kerrouche; B Desgranges; F Eustache; B Beuthien-Baumann; C Menzel; J Schröder; T Kato; Y Arahata; M Henze; W D Heiss
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

Review 3.  Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.

Authors:  Stefan J Teipel; Osama Sabri; Michel Grothe; Henryk Barthel; David Prvulovic; Katharina Buerger; Arun L W Bokde; Michael Ewers; Wolfgang Hoffmann; Harald Hampel
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses.

Authors:  Jeffrey S Spence; Patrick S Carmack; Richard F Gunst; William R Schucany; Wayne A Woodward; Robert W Haley
Journal:  Neuroimage       Date:  2006-05-02       Impact factor: 6.556

5.  Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.

Authors:  Silvia Morbelli; Alex Drzezga; Robert Perneczky; Giovanni B Frisoni; Anna Caroli; Bart N M van Berckel; Rik Ossenkoppele; Eric Guedj; Mira Didic; Andrea Brugnolo; Gianmario Sambuceti; Marco Pagani; Eric Salmon; Flavio Nobili
Journal:  Neurobiol Aging       Date:  2012-02-23       Impact factor: 4.673

6.  Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease.

Authors:  Ralph Buchert; Florian Wilke; Bhismadev Chakrabarti; Brigitte Martin; Winfried Brenner; Janos Mester; Malte Clausen
Journal:  J Neuroimaging       Date:  2005-10       Impact factor: 2.486

7.  Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.

Authors:  Anna Caroli; Annapaola Prestia; Kewei Chen; Napatkamon Ayutyanont; Susan M Landau; Cindee M Madison; Cathleen Haense; Karl Herholz; Flavio Nobili; Eric M Reiman; William J Jagust; Giovanni B Frisoni
Journal:  J Nucl Med       Date:  2012-02-17       Impact factor: 10.057

Review 8.  Early detection of Alzheimer's disease with PET imaging.

Authors:  V Berti; R S Osorio; L Mosconi; Y Li; S De Santi; M J de Leon
Journal:  Neurodegener Dis       Date:  2010-03-03       Impact factor: 2.977

9.  Accuracy of spatial normalization of the hippocampus: implications for fMRI research in memory disorders.

Authors:  Sriyesh Krishnan; Melissa J Slavin; Thanh-Thu T Tran; P Murali Doraiswamy; Jeffrey R Petrella
Journal:  Neuroimage       Date:  2006-03-02       Impact factor: 6.556

10.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Authors:  Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles S DeCarli; R Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
Journal:  Brain       Date:  2007-08-18       Impact factor: 13.501

View more
  96 in total

Review 1.  Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

Authors:  Peter J Nestor; Daniele Altomare; Cristina Festari; Alexander Drzezga; Jasmine Rivolta; Zuzana Walker; Femke Bouwman; Stefania Orini; Ian Law; Federica Agosta; Javier Arbizu; Marina Boccardi; Flavio Nobili; Giovanni Battista Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

2.  Building a FP-CIT SPECT Brain Template Using a Posterization Approach.

Authors:  D Salas-Gonzalez; Juan M Górriz; Javier Ramírez; Ignacio A Illán; Pablo Padilla; Francisco J Martínez-Murcia; Elmar W Lang
Journal:  Neuroinformatics       Date:  2015-10

3.  Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies.

Authors:  Arianna Sala; Silvia Paola Caminiti; Leonardo Iaccarino; Luca Beretta; Sandro Iannaccone; Giuseppe Magnani; Alessandro Padovani; Luigi Ferini-Strambi; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2019-07-19       Impact factor: 5.038

4.  Early identification of MCI converting to AD: a FDG PET study.

Authors:  Marco Pagani; Flavio Nobili; Silvia Morbelli; Dario Arnaldi; Alessandro Giuliani; Johanna Öberg; Nicola Girtler; Andrea Brugnolo; Agnese Picco; Matteo Bauckneht; Roberta Piva; Andrea Chincarini; Gianmario Sambuceti; Cathrine Jonsson; Fabrizio De Carli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-29       Impact factor: 9.236

5.  Validation of 18F-FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners.

Authors:  Luca Presotto; Tommaso Ballarini; Silvia Paola Caminiti; Valentino Bettinardi; Luigi Gianolli; Daniela Perani
Journal:  Neuroinformatics       Date:  2017-04

6.  Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease.

Authors:  Tommaso Ballarini; Leonardo Iaccarino; Giuseppe Magnani; Nagehan Ayakta; Bruce L Miller; William J Jagust; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2016-07-13       Impact factor: 5.038

7.  Gender differences in healthy aging and Alzheimer's Dementia: A 18 F-FDG-PET study of brain and cognitive reserve.

Authors:  Maura Malpetti; Tommaso Ballarini; Luca Presotto; Valentina Garibotto; Marco Tettamanti; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2017-05-31       Impact factor: 5.038

8.  FDG-PET patterns associated with underlying pathology in corticobasal syndrome.

Authors:  Matteo Pardini; Edward D Huey; Salvatore Spina; William C Kreisl; Silvia Morbelli; Eric M Wassermann; Flavio Nobili; Bernardino Ghetti; Jordan Grafman
Journal:  Neurology       Date:  2019-01-30       Impact factor: 9.910

9.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

10.  Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment.

Authors:  Eun Hyun Seo; I L Han Choo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.